Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
12/7/14: Man tests negative for Ebola in Seattle
http://seattletimes.com/html/localnews/2025186980_ebolatestxml.html
Thanks, ET281.
That article was a pretty interesting read.
Care to post some verifiable info - street maps, website links with address of GSK and Caliber, etc?
Thanks in advance.
12/6/14: As Ebola Rages, Poor Planning Thwarts Efforts
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835432
12/6/14: As Ebola Rages, Poor Planning Thwarts Efforts
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835432
12/6/14: As Ebola Rages, Poor Planning Thwarts Efforts
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835432
12/6/14: As Ebola Rages, Poor Planning Thwarts Efforts
http://www.nytimes.com/2014/12/07/world/africa/as-ebola-rages-in-sierra-leone-poor-planning-thwarts-efforts.html?_r=0
KERRY TOWN, Sierra Leone — On a freshly cleared hillside outside the capital, where the trees have been chopped down and replaced with acres of smooth gravel, the new Ebola treatment center seems to have everything. There are racks of clean pink scrubs and white latex boots, bathrooms that smell like Ajax, solar-powered lights, a pharmacy tent, even a thatch-roofed hut to relax in.
But one piece is missing: staff. The facility opened recently with a skeleton crew. Now, in an especially hard-hit area where people are dying every day because they cannot get into an Ebola clinic, 60 of the 80 beds at the Kerry Town Ebola clinic are not being used.
It is like this with a lot here: good intentions, bad planning. Aid officials in Sierra Leone say poor coordination among aid groups, government mismanagement and some glaring inefficiencies are costing countless lives.
Ambulances, for example, are being used to ferry blood samples, sometimes just one test tube at a time, while many patients die at home after waiting days for an ambulance to come.
Half of the patients in some front-line Ebola clinics do not even have Ebola, but their test results take so long that they end up lingering for days, taking beds from people whose lives hang in the balance and greatly increasing their own chances of catching the virus in such close quarters.
Even after patients recover, many treatment centers delay releasing them for more than a week until there are enough other survivors, sometimes dozens, to hold one huge goodbye ceremony for everyone — again, keeping desperately needed beds occupied. “I just wanted to get home and see my wife,” said Suliman Wafta, a recent Ebola survivor treated nearby. “But I had to wait eight extra days.”
The latest Ebola numbers are ominous. This past week, Sierra Leone reported almost 100 new cases in a single day, nearly double the number just 10 days before — and those are only the confirmed cases, which health experts say may be a third of the total. At this rate, the swelling roster of the gravely ill will far outstrip even the most optimistic projections for new hospital beds.
The recriminations are beginning to fly, especially against Britain, which, in a colonial-style carve-up of Ebola-afflicted countries, is the international power taking the lead here.
“Why are the British here? To end Ebola, or party?” read a headline in a local newspaper. It added, “While their American counterparts are working hard to end Ebola in Liberia, our so-called colonial masters are busy living the life of Riley.”
British officials say that is not true, and that the 800 or so soldiers deployed here, who are building new treatment centers and training medics, are not allowed even a beer. “We’re working from 7 a.m. to 10 p.m., seven days a week,” said Maj. Simon Reeves, a spokesman.
A big question people here are beginning to ask is whether the American military, which has sent 2,400 troops to Liberia, has any appetite to come to Sierra Leone. Many aid officials say the Pentagon’s role in building treatment centers, establishing mobile blood labs and ferrying Ebola supplies around Liberia has helped slow the epidemic there.
An Obama administration official in Washington said that no decision had been made to shift American troops from Liberia to Sierra Leone or send in large numbers of reinforcements, but that “nothing is off the table.”
Like others, the official kept citing the “Brits’ primacy” in Sierra Leone — a reference to how, several months ago, Western powers divided Ebola responsibilities in West Africa along historical lines, with the United States helping Liberia, a nation founded by freed American slaves in 1822; France helping a former colony, Guinea; and Britain helping its own former colony, Sierra Leone.
According to several other American officials, the Pentagon was not enthusiastic about getting involved in Liberia in the first place and is resistant to going deeper into the region.
“They basically said, ‘We know conflict, but we don’t know Ebola,' ” said one American official in West Africa. The military is also tired from fighting two long wars, the official said.
The Pentagon press secretary, Rear Adm. John F. Kirby, said the Defense Department was continuing to “monitor the spread of Ebola,” and was “mindful that it doesn’t just exist in Liberia.” In the next month, it will send two mobile blood labs to Sierra Leone to help reduce the bottlenecks caused by delays in testing.
Many aid officials in Sierra Leone said they crave a more effective command structure. The government runs a national emergency center, but aid officials said that with scores of foreign experts, government delegations and private charities flocking here, coordination was still messy, with many gaps and overlaps. It is extremely difficult, they said, to get even the most basic information, including how many treatment centers exist.
There are also growing questions about corruption, with the government announcing recently that it had found 6,000 “ghost medical workers” on its payroll, even as real Ebola burial teams and front-line health officers say they have not been paid in weeks.
Over and over, doctors have been confounded by the divergent paths of Ebola patients whose cases appeared similar at first.
Nothing, though, has raised more eyebrows than the new Kerry Town Ebola clinic, about a half-hour’s drive from the capital, Freetown. The clinic is an impressive campus of blue and white buildings lined up in perfectly straight rows, with all the orderliness of a military camp. It remains quiet, though, without enough trained nurses or hygienists to operate safely at anywhere close to capacity.
Several aid officials said that the Sierra Leonean government had been in a rush to open the clinic, but that the aid group tasked with running it, Save the Children International, had never run a critical-care field hospital. The rows of empty beds have led to some nasty finger-pointing.
Save the Children officials said the government had “begged” them to run the clinic. The government said Britain had made the decision. And the Britons said they had had no choice because no one else wanted the task.
The Save the Children officials said Saturday that they had asked for eight more Ebola patients per day but were receiving only one.
“That place is like a boat without a captain,” a senior international aid official said. “Everybody’s rowing in different directions, and the boat doesn’t move.”
The British military said that it was close to completing several other clinics, but that it would take time, just as it did in Liberia, to turn the crisis around here.
Usually, in big emergencies where many people are in desperate need, the United Nations Office for the Coordination of Humanitarian Affairs plays a huge role, dividing services into clusters and then coordinating the work of private aid groups within each cluster. Ensuring “a coherent response to emergencies” is its raison d'être.
All across the refugee camps and war zones of Sudan, Central African Republic and the Democratic Republic of Congo, to name a few, are legions of young aid workers scrambling around in vests stamped with “OCHA,” as the office is known. But in Sierra Leone right now, there very few are seen. “I have no idea why OCHA isn’t doing this, and I think OCHA has no idea why they’re not doing this,” said Michael von Bertele, the global humanitarian director for Save the Children.
One United Nations official, who was not authorized to speak publicly, said OCHA defined the Ebola crisis as a “systemic medical issue.” “Corporately, this is not a humanitarian emergency,” she said, but conceded that most aid agencies viewed it as one.
The United Nations still seems to be struggling with how to respond to one of the biggest international health crises in decades. After a lackluster start by the World Health Organization, Secretary General Ban Ki-moon established a separate Ebola mission in September to speed up the international response and cut through some of the typical United Nations bureaucracy.
Anthony Banbury, the head of that mission, said the United Nations was helping with crisis management and that OCHA had sent “a number of information officers” to the region. He also said that the Sierra Leonean government was handling coordination “very effectively.”
Many Sierra Leoneans find that laughable, but some said that because the government had declared a state of emergency, they had to speak carefully.
“Everybody knows there are huge gaps,” said Ibrahim Tommy, a human rights campaigner in Freetown. “But nobody can say anything.”
Several journalists and intellectuals have been summoned to Parliament recently to defend their work, and last month a prominent radio host was locked up for 11 days after he asked some questions about the government’s Ebola response. A government spokesman said that the radio host had been jailed for other reasons, without specifying them, and that there was no repression in Sierra Leone.
The journalist, David Tam-Baryoh, called the experience terrifying. “The government is getting very edgy,” he said.
When asked what grade he would give the government for its handling of Ebola, Mr. Tam-Baryoh giggled nervously.
“Well, if I wasn’t in the country,” he started to say. “But I don’t even want to say that. The powers of emergency could be wrongly used, to put it mildly.”
Jaime Yaya Berry contributed reporting from Freetown, Sierra Leone, Eric Schmitt from Kuwait and Helene Cooper from Washington.
12/7/14: MIT Had Cure for Ebola back in 2011, Ignored by Media
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835286
12/7/14: MIT Had Cure for Ebola back in 2011, Ignored by Media
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835286
12/7/14: MIT Had Cure for Ebola back in 2011, Ignored by Media
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108835286
12/7/14: MIT Had Cure for Ebola back in 2011, Ignored by Media
http://macedoniaonline.eu/content/view/26572/54/
Sunday, 07 December 2014
A major breakthrough out of MIT (Massachusetts Institute of Technology) shows incredible promise as a cure for virtually every kind of viral infection known to man. This research has been completely ignored by the mainstream media who prefers to sell us vaccines by their major advertisers - Big Pharma.
Scientists from the school's Lincoln Laboratory basically came up with a method of targeting viruses that destroys infected cells while leaving healthy cells unharmed, similar to how antiviral nutrients function. But here's the kicker: The discovery was made in 2011, three years before the current Ebola outbreak, though it hasn't received any media attention whatsoever.
Published in the journal PLOS ONE, a groundbreaking study on this novel therapeutic explains how existing antiviral medications are scarce, and many of them largely ineffective. Viable treatments for the common cold, for example, are practically nonexistent, while newer diseases like SARS are regarded by public health officials as basically untreatable.
"In theory, it should work against all viruses," stated Todd Rider, a senior staff scientist from the Lincoln Laboratory's Chemical, Biological and Nanoscale Technologies Group and inventor of the technology, to MIT News.
DRACOs tell virus-infected cells to kill themselves
So what is this mysterious technological advancement? The paper calls them DRACOs, which is short for Double-stranded RNA Activated Caspase Oligomerizers. In essence, it is a substance that induces apoptosis, or cell death, in cells containing viral dsRNA, the double-stranded RNA produced by viruses for the purpose of replication.
Human cells are naturally pre-programmed to create special proteins that destroy these dsRNA strands, but viruses can mutate to outsmart and bypass this safeguard. This is where DRACOs come in, adding an additional protein into the mix that triggers apoptosis in infected cells. This combined approach is not only effective against virtually all tested viruses, but it also eliminates the possibility of viral resistance.
"Viruses are pretty good at developing resistance to things we try against them," stated Karla Kirkegaard, a professor of microbiology and immunology at Stanford University, to MIT News about the development. "[B]ut in this case, it's hard to think of a simple pathway to drug resistance."
DRACOs don't harm healthy cells
The best part about DRACO technology is that it leaves uninfected cells alone, which can't be said for the array of pharmaceuticals currently on the market, including chemotherapy drugs that kill everything in their path. Tests conducted both in vitro (in a test tube) and in vivo (in living organisms) show that DRACO is capable of killing the H1N1 influenza virus without causing any harm.
"DRACOs should be effective against numerous clinical and NIAID priority viruses, due to the broad-spectrum sensitivity of the dsRNA detection domain, the potent activity of the apoptosis induction domain, and the novel direct linkage between the two which viruses have never encountered," wrote the authors.
"We have demonstrated that DRACOs are effective against viruses with DNA, dsRNA, positive-sense ssRNA, and negative-sense ssRNA genomes; enveloped and non-enveloped viruses; viruses that replicate in the cytoplasm and viruses that replicate in the nucleus; human, bat, and rodent viruses; and viruses that use a variety of cellular receptors."
This clearly represents an extensive array of efficacy that is unmatched by any drugs currently on the market, yet DRACOs have received little media attention since they were first announced. Though they obviously require much more extensive testing to ensure safety, DRACOs appear to have taken a back seat to vaccines, which are the only type of intervention that government health officials seem to care about these days. //J. Benson NN
12/6/14: Seattle Health officials testing man for Ebola
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108832347
12/6/14: Seattle Health officials testing man for Ebola
http://www.komonews.com/news/local/Health-officials-testing-man-for-Ebola-at-Harborview-284987091.html?mobile=y
By KOMO Staff Dec 6, 2014
SEATTLE - A man living in King County is being tested for Ebola at Harborview Medical Center in Seattle, James Appa with Public Health King County said Saturday.
The man had been traveling from Mali with his son, and developed a low grade fever and sore throat Friday night.
The possibility of the man having Ebola is relatively low, officials said. He is in "good spirits," and is currently isolated as a precaution.
The Mali-born man had been visiting family for three weeks, and has been under routine monitoring by health officials since arriving in Seattle.
Health officials have taken precautions to minimize the risk of the disease spreading to the public by checking all who came in contact with the man.
"The risk to the general public remains extremely low," Dr. Duchin said Saturday.
Harborview Medical Center is also reducing risk of the disease spreading by implementing an Ebola response plan, Appa said.
The results for the test are expected to be ready at least 12 hours after the test arrives at the lab, and will be released by public health officials when they are available.
As long as there are people who are happily handing over their cash with the "get rich quick" mentality and are too lazy to do real research on these companies they play, the scam tickers can go on and on.
Some of these people will believe a random poster wants to help them make money and just so happens to know information on when a PR will be released, etc.
The lazy with the wrong mentality and expectations will get fleeced over and over again.
12/6/14: Doc treated at UK-run Ebola military clinic in Sierra Leone dies
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108826330
12/6/14: Doc treated at UK-run Ebola military clinic in Sierra Leone dies
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108826330
12/6/14: Doc treated at UK-run Ebola military clinic in Sierra Leone dies
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108826330
12/6/14: Doc treated at UK-run Ebola military clinic in Sierra Leone dies
http://www.theguardian.com/world/2014/dec/06/doctor-treated-british-run-ebola-clinic-sierra-leone-dies
A doctor who was being treated at an Ebola clinic run by British military medical staff in Sierra Leone has died.
The death of Thomas Rogers at the clinic in Kerry Town on Friday brings the number of doctors in Sierra Leone who have been killed by the deadly virus to eight. He had worked at Connaught hospital in Freetown, the capital of the country where Ebola is spreading fastest.
Ebola has now infected more than 17,500 people, mostly in Guinea, Liberia and Sierra Leone, and killed about 6,200. He was the 11th doctor in Sierra Leone to have been infected with the virus.
The clinic, which opened in early November, included an 80-bed treatment centre managed by Save the Children and a 12-bed centre staffed by British Army medics specifically for healthcare workers and international staff responding to the Ebola crisis.
The high number of infections in healthworkers deters many from volunteering to work on Ebola wards, particularly local healthworkers. While foreign doctors and nurses who have become infected have been evacuated for treatment at better-equipped foreign hospitals, locals are almost always treated in their own countries. Facilities such as the one at Kerry Town have been set up in an attempt to response to that disparity. Another has been established in Liberia and another is planned for Guinea.
A Cuban doctor being treated for Ebola at Geneva University Hospital has made a full recovery and left Switzerland to be reunited with his family, the hospital said on Saturday.
Felix Baez Sarria, 43, was evacuated from Sierra Leone on 19 November after coming down with a fever. He was believed to have contracted the virus after rushing to help a patient who was falling over. Sarria was one of 256 Cuban doctors and nurses who have travelled to west Africa to help tackle the worst outbreak of the disease.
Ebola is spread through the bodily fluids of people showing symptoms and people who have died of the disease. Because transmission requires close contact with those fluids, health workers are among the most at risk of contracting it and hundreds have become infected in this outbreak.
Meanwhile, a second wave of 25 doctors, nurses and other medical staff from across the UK are due to arrive in Sierra Leone on Saturday to join 30 NHS volunteers who travelled there last month. They had five days of intensive training in Worcestershire before departing and will undergo further training and acclimatisation before starting work at the British-built treatment centres.
Staff nurse Hannah McReynolds, from Leicester, said she felt privileged to be part of the team. “As soon as I heard NHS staff were volunteering I didn’t hesitate to apply. I feel lucky to have been born into a society which has provided me with free education and healthcare. This is a global issue and I am proud of my colleagues who have volunteered and want to encourage others to do so.”
Health secretary Jeremy Hunt paid tribute to the NHS volunteers: “They embody the values at the heart of our health service, and their expertise and dedication is second to none.”
The Cuban doctor in the story above that was treated and recovered was treated with the ZMapp drug.
Read what you quoted me saying again.
Sorry to hear that. I remember losing thousands in OTC stocks before I decided to get off of the OTC "drug" once and for all besides occasionally playing FNMA and FMCC. It's the same pattern over and over. Issue outlandish PRs, dilute and reverse split over and over until the ticker is completely killed.
Don't count on the SEC to save you. Your hero is in the nearest mirror that you can get to. The best way to fight scam companies is to not give them your money at all.
Take the lessons you learned here and come on over to the Big Boards where your chances of making money are much better than playing p*ss a$$ OTC stocks.
No problem. It's about to get very, very interesting in the reputable Ebola-related stocks.
BOOM! - 12/5/14: Legislation to add Ebola to FDA’s Priority Review Voucher Program clears Congress
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108815398
Keeping my eyes on the bigger picture!
12/5/14: Legislation to add Ebola to FDA’s Priority Review Voucher Program clears Congress
http://riponadvance.com/news/legislation-add-ebola-fdas-priority-review-voucher-program-clears-congress/9842
Legislation to add Ebola to FDA’s Priority Review Voucher Program clears Congress
By Aaron Martin | December 5, 2014
Legislation that would add Ebola to the FDA’s Priority Review Voucher program cleared both the Senate and the House this week.
The Adding Ebola to the FDA Priority Review Voucher Program Act would provide a voucher for priority FDA review of a future drug to those who successfully develop therapies and vaccines for Ebola.
Rep. Marsha Blackburn (R-Tenn.), who introduced the measure in the House, said decreasing the time it takes for a company to bring a drug through the FDA approval process would be a great incentive for the development of Ebola drugs.
“With nearly 15,000 cases and over 5,000 deaths, the 2014 Ebola epidemic is the worst since the discovery of the virus in 1976,” Blackburn, the vice chairwoman of the House Energy and Commerce Committee, said. “In light of this global outbreak there should be an intensive effort to find and approve a treatment or better yet, a vaccine to prevent Ebola.”
Blackburn worked with Sen. Lamar Alexander (R-Tenn.), who co-sponsored the measure in the Senate, on the Adding Ebola to the FDA Priority Review Voucher Program Act.
“The world is in desperate need of a vaccine to prevent Ebola and a drug to treat it,” Alexander, the ranking member of the Senate Health, Education, Labor and Pensions Committee, said. “I’m glad the Senate has moved quickly to pass this bill to spur the development of these vaccines and drugs — an important step in the fight against Ebola, which we hope will one day help lead to a cure.”
HR 5729: https://www.congress.gov/113/bills/hr5729/BILLS-113hr5729ih.pdf
Original PR from Congressman Blackburn's site: http://blackburn.house.gov/news/documentsingle.aspx?DocumentID=397636
Something just came to me. As I am searching for various information on Ebola and treatment development, a thought came to me.
I am coming across other private companies that are submitting products for testing or use in treating ebola patients.
This is just a thought; what if IBIO is aware of some of these companies and have registered the $100M shelf to acquire some of these companies? Just a thought as I am seeing quite a few interesting companies in my search but they are not public.
Examples: http://media.wix.com/ugd/f7710c_4de645cc71134d45ad265662a3a205c6.pdf
https://www.zenopa.com/news/801764629/integrated-dna-technologies-and-ubiquitome-to-develop-mobile-ebola-test
The two links above are interesting (and private) and quite possibly potential targets for IBIO. Hmm.....
12/5/14: Ebola survivor speaks of ending suffering in West Africa
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108815112
12/5/14: Ebola survivor speaks of ending suffering in West Africa
http://www.cbc.ca/news/health/dr-kent-brantly-ebola-survivor-speaks-of-ending-suffering-in-west-africa-1.2861586
American doctor was discharged from hospital in August after contracting Ebola in Liberia
The Canadian Press Posted: Dec 05, 2014 9:29 AM ET Last Updated: Dec 05, 2014 1:38 PM ET
An American doctor who survived the Ebola virus says he'd like to eventually return to West Africa, the place where he
got sick.
For now, Dr. Kent Brantly says his experience has given him a platform to raise awareness about the virus.
But he says he would like to return to medical work in Liberia at some point.
"I understand in a new way how people in West Africa are suffering," Brantly said. "I fully acknowledge I cannot fathom, I cannot understand what it's like to be a West African with Ebola because I had opportunity and resources that are not available to every person."
Brantly was in Ottawa on behalf of the aid group Samaritan's Purse to talk about the group's use of recent federal funding.
Brantly, a Texan, was given ZMapp, an experimental drug treatment used on a handful of patients and produced by U.S.-based Mapp Biopharmaceutical.
He was discharged from an Atlanta hospital in August.
"This has affected countries on multiple continents and we've got to work together to bring an end to it," he told a news conference.
Brantly said he's thankful he received ZMapp, but much more data is needed before anyone can say the drug treats most cases of Ebola.
In November, another American Ebola survivor, Nancy Writebol, visited Winnipeg. During her visit to a church, Writebol thanked scientists from the National Microbiology Laboratory in Winnipeg who helped develop ZMapp, which she also received.
For now, Brantly encouraged people to focus on intervening in communities to stop transmission of the virus.
Similarly, Brantly said in his opinion, the preventative benefits offered by potential vaccines could offer a greater impact on the outbreak than experimental drugs.
The United Nations Mission for Ebola Emergency Response (UNMEER) aimed to isolate and treat all Ebola cases and safely bury all those who died, by Jan. 1.
The Ebola outbreak has made nearly 17,300 people sick, with most in Guinea, Liberia and Sierra Leone. Of those, about 6,100 have died, the World Health Organization says.
With files from CBC News and The Associated Press
This is one reason why these price drops are not moving me. The bigger picture looks awesome. Also, I was reading through the last Q report. I saw lots and lots of good stuff on the horizon, in my opinion.
It's possible but very unlikely since we have some more news items coming out slowly but surely. The short sellers will have to run this down hard and fast consistently. Currently, they are running it down very carefully and covering not too far from the point they begin dropping.
12/10/14: Senate Hearing: The Ebola Epidemic: The Keys To Success for The International Response.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812639
12/3/14 Video: Defense Dept Briefing on Ebola Response
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812621
General David Rodriquez briefed reporters and responded to questions on the U.S. military response to the Ebola outbreak in West Africa.
12/3/14 Video: Defense Dept Briefing on Ebola Response
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812621
General David Rodriquez briefed reporters and responded to questions on the U.S. military response to the Ebola outbreak in West Africa.
12/10/14: Senate Hearing: The Ebola Epidemic: The Keys To Success for The International Response.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812639
12/10/14: Senate Hearing: The Ebola Epidemic: The Keys To Success for The International Response.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812639
12/3/14 Video: Defense Dept Briefing on Ebola Response
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812621
General David Rodriquez briefed reporters and responded to questions on the U.S. military response to the Ebola outbreak in West Africa.
12/10/14: Senate Hearing: The Ebola Epidemic: The Keys To Success for The International Response.
http://www.foreign.senate.gov/hearings/the-ebola-epidemic-the-keys-to-success-for-the-international-response
Subcommittee on African Affairs
Date: Wednesday, December 10, 2014
Time: 10:30 AM
(more info through the link above)
12/3/14 Video: Defense Dept Briefing on Ebola Response
http://www.c-span.org/video/?323061-1/department-defense-briefing-ebola-response
General David Rodriquez briefed reporters and responded to questions on the U.S. military response to the Ebola outbreak in West Africa.
12/5/14: Cuba says infected doctor overcomes Ebola
He was treated with the drug ZMapp.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108811802
12/5/14: Sierra Leone seeing 80-100 new Ebola cases daily
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108811927
12/5/14: UN peacekeeper in Liberia tests positive for Ebola
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108812049